Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/B9A stock hub

FRA/B9A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/B9Ais not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/B9A

In the news

Latest news · FRA/B9A

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E27.5

P25 n/aP50 n/aP75 n/a

ROE71.4

P25 n/aP50 n/aP75 n/a

ROIC57.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/B9A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

SEK

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	DE
Employees	129
Employees Change	22%
Employees Change Percent	20.56
Enterprise value	EUR 2.4B
Exchange	Frankfurt Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 2.6B
Price	EUR 29.94
Price currency	EUR
Rev Per Employee	1,431,965.26x
Sic	2836
Symbol	fra/B9A
Website	https://www.bioarctic.se

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.64%
EV Earnings	25.38x
EV/EBIT	19.03x
EV/EBITDA	18.82x
EV/FCF	18.26x
EV/Sales	13.02x
FCF yield	5.06%
P/B ratio	14.28x
P/E ratio	27.48x
P/S ratio	14.05x
PE Ratio3 Y	55.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	68.44%
FCF margin	71.07%
Gross margin	97.04%
Gross Profit	EUR 179.3M
Gross Profit Growth	742.09%
Gross Profit Growth Q	89.04%
Gross Profit Growth3 Y	132.12%
Gross Profit Growth5 Y	164.57%
Net Income	EUR 94.5M
Pretax Margin	62.81%
Profit Margin	51.14%
Profit Per Employee	EUR 732,292
ROA	46.39
Roa5y	8.01
ROCE	66.6
ROE	71.44
Roe5y	12.53
ROIC	57.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	75.26%
Cagr3y	5.86%
Cagr5y	29.95%
Revenue Growth	676.8x
Revenue Growth Q	81.79x
Revenue Growth3 Y	105.78x
Revenue Growth5 Y	98.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.08
Assets	EUR 238M
Cash	EUR 202.4M
Current Assets	EUR 228.8M
Current Liabilities	EUR 47.9M
Debt	EUR 4.1M
Debt EBITDA	EUR 0.03
Debt Equity	EUR 0.02
Debt FCF	EUR 0.03
Equity	EUR 181.8M
Interest Coverage	675.3
Liabilities	EUR 56.2M
Long Term Assets	EUR 9.1M
Long Term Liabilities	EUR 8.3M
Net Cash	EUR 198.3M
Net Cash By Market Cap	EUR 7.64
Net Cash Growth	196.18%
Net Debt Equity	EUR -1.09
Net Debt FCF	EUR -1.51
Tangible Book Value	EUR 181.8M
Tangible Book Value Per Share	EUR 2.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.78
Net Working Capital	EUR -19.3M
Quick ratio	4.76
Working Capital	EUR 181.7M
Working Capital Turnover	EUR 0.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.23%
Dividend per share	EUR 0
Last Dividend	EUR 0.14

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	75.19%
200-day SMA	27.24
3Y total return	18.62%
50-day SMA	29.03
50-day SMA vs 200-day SMA	50over200
5Y total return	270.55%
All Time High	34.96
All Time High Change	-14.36%
All Time High Date	2026-02-18
All Time Low	4.27
All Time Low Change	601.17%
All Time Low Date	2020-03-24
ATR	0.58
Ch YTD	4.18
High	29.94
High52	34.96
High52 Date	2026-02-18
High52ch	-14.36%
Low	29.94
Low52	15.63
Low52 Date	2025-05-14
Low52ch	91.56%
Ma50ch	3.13%
Price vs 200-day SMA	9.92%
RSI	53.16
RSI Monthly	63.7
RSI Weekly	56.53
Sharpe ratio	1.34x
Sortino ratio	2.41
Total Return	-0.23%
Tr YTD	4.18
Tr1m	0.54%
Tr1w	1.01%
Tr3m	4.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 126.4M
Operating margin	68.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,395,820%
Net Borrowing	81,891.4
Shares Insiders	32.2%
Shares Institutions	43.69%
Shares Qo Q	0.06%
Shares Yo Y	0.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 129.1M
Average Volume	0x
Bv Per Share	2.05
CAPEX	EUR -946,482
Ch1m	0.54
Ch1w	1.01
Ch1y	75.19
Ch3m	4.91
Ch3y	18.62
Ch5y	270.5
Ch6m	22.71
Change	-0.66%
Change From Open	0
Close	30.14
Days Gap	-0.66
Depreciation Amortization	1,399,054
Earnings Date	2026-04-21
EBIT	EUR 126.4M
EPS	EUR 1.06
F Score	6
FCF	EUR 131.3M
FCF EV Yield	5.48x
Financing CF	2,486,006
Fiscal Year End	December
Founded	2,000
Graham Number	7.16969
Graham Upside	-76.05
Income Tax	EUR 21.6M
Investing CF	-82,667,916
Is Primary Listing	0
Last Earnings Date	2026-04-21
Last Report Date	2025-12-31
Ma150	28.64
Ma150ch	4.55%
Ma20	29.62
Ma20ch	1.07%
Net CF	48,742,771
Next Earnings Date	2026-05-15
Open	29.94
P FCF Ratio	19.77
P OCF Ratio	19.63
Ppne	7,635,586.9
Price Date	2026-05-08
Ptbv Ratio	14.28
Relative Volume	20x
Revenue	184,723,518x
SBC By Revenue	1.2x
Share Based Comp	2,221,734
Tax By Revenue	11.67x
Tax Rate	18.58%
Tr6m	22.71%
Z Score	24.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/B9A pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/B9A stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/B9A?

Insider, institutional, and short-interest positioning.

Institutional ownership

+43.7%

Share of float held by funds and institutions

Insider ownership

+32.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

FRA/B9A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.2

Neutral momentum band

Price vs 200-day MA

+9.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/B9A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/B9A stock rating?

fra/B9A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/B9A analysis?

The full report lives at /stocks/fra/B9A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/B9A?

The latest report frames fra/B9A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/B9A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.